ANIK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anika Therapeutics Inc

Watchlist Manager

Watchlist

Price: 19.36 USD -1.53% Market Closed

Market Cap: $259m

	Anika Therapeutics Inc NASDAQ:ANIK	US
H	Henkel AG & Co KGaA DUS:HEN	DE
C	Celanese Corp LSE:0HUR	US
	Fidus Investment Corp NASDAQ:FDUS	US
C	Caster Co Ltd TSE:9331	JP

Profitability Summary

Anika Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

62% > 62%

Negative Operating Margin

-2%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-15% > -2%

Negative Net Margin

-3%

Negative 3Y Average Net Margin

-35%

Net Margin is Increasing

-15% > -3%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-7% > 0%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-6%

ROIC is Increasing

-8% > -2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.